Sponsor of the Day:
Jerkmate
https://www.thepharmanavigator.com/news/abbvie-remegen-sign-exclusive-licensing-agreement-for-novel-bispecific-antibody
AbbVie, RemeGen Sign Exclusive Licensing Agreement for Novel Bispecific Antibody — The Pharma...
Jan 14, 2026 - The agreement will allow AbbVie to develop, manufacture, and commercialize RemeGen’s novel PD-1/VEGF bispecific antibody in combination with its ADCs across...
sign exclusivelicensing agreementbispecific antibodyabbvienovel
https://www.genengnews.com/multimedia/webinars/data-driven-strategies-for-addressing-bispecific-antibody-purification-challenges/
Data-Driven Strategies for Addressing Bispecific Antibody Purification Challenges
Mar 25, 2026 - In this GEN webinar, Joshua Orchard, a purification applications scientist with extensive experience in downstream process development of various modalities,...
data driven strategiesbispecific antibodyaddressingpurificationchallenges
https://www.hcahealthcare.co.uk/about-us/news-and-press-releases/first-lung-cancer-patient-treated-at-hca-uk-hospital-with-pioneering-bispecific-antibody-therapy
Pioneering bispecific antibody therapy | HCA UK
HCA UK’s The Harborne Hospital in Birmingham has become the first facility in the West Midlands to treat a lung cancer patient using bispecific antibody...
bispecific antibodyhca ukpioneeringtherapy